1332850-64-2

Upstream product

• 1332850-63-1 (4S,5R,6R,E)-6-((S)-1,2-bis(benzyloxy)ethyl)-4-benzyloxy-5-fluoroocta-2,7-diene 
• 1332850-62-0 (4S,5R,6R,E)-6-((S)-1,2-bis(benzyloxy)ethyl)-5-fluoroocta-2,7-dien-4-ol 
• 1332850-48-2 C₂₄H₂₇FO₃ 

Downstream Products

• 1332850-65-3 (3S,4R,5R)-1-benzyl-3-(benzyloxy)-5-((S)-1,2-bis(benzyloxy)ethyl)-4-fluoropiperidine 
• 1332850-66-4 (S)-1-((3R,4R,5S)-1-benzyl-4-fluoro-5-hydroxypiperidin-3-yl)ethane-1,2-diol 
• 1332850-67-5 (S)-1-((3R,4R,5S)-1-benzyl-4-fluoro-5-((4-nitrobenzoyl)oxy)piperidin-3-yl)ethane-1,2-diyl bis(4-nitrobenzoate) 
• 1332850-68-6 (3S,4R,5R)-1-benzyl-4-fluoro-5-(hydroxymethyl)piperidin-3-ol 

Relevant academic research and scientific papers

Synthesis of monofluorinated isofagomine analogues and evaluation as glycosidase inhibitors

The straightforward synthesis of monofluorinated isofagomine analogues 1-3 was described. The synthetic strategy featured that the chiral carbon center bearing fluorine atom was constructed stereoselectively via silicon-induced Reformatskii-Claisen rearra